𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

✍ Scribed by Thomas Decker; Michael Sandherr; Katharina Goetze; Madlen Oelsner; Ingo Ringshausen; Christian Peschel

Publisher
Springer
Year
2008
Tongue
English
Weight
151 KB
Volume
88
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase 2 study of the oral mammalian ta
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma
✍ Brian M. Slomovitz; Karen H. Lu; Taren Johnston; Robert L. Coleman; Mark Munsell πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: Dysregulation of phosphatase and tensin homolog (PTEN) and the gene that encodes the p110Ξ± catalytic subunit of phosphatidylinositol‐3‐kinase (PI3K), PIK3CA, are the most common mutations in endometrial carcinoma (EC). Loss of PTEN or activation of PIK3CA results in cons